Effects of rolipram, a phosphodiesterase 4 inhibitor, in combination with imipramine on depressive behavior, CRE-binding activity and BDNF level in learned helplessness rats

European Journal of Pharmacology
Tetsuji ItohKohji Abe

Abstract

The brain cAMP regulating system and its downstream elements play a pivotal role in the therapeutic effects of antidepressants. We previously reported the increase in activities of phosphodiesterase 4, a major phosphodiesterase isozyme hydrolyzing cAMP, in the frontal cortex and hippocampus of learned helplessness rats, an animal model for depression. The present study was undertaken to examine the combination of effects of rolipram, a phosphodiesterase 4 inhibitor, with imipramine, a typical tricyclic antidepressant, on depressive behavior in learned helplessness rats. Concurrently, cAMP-response element (CRE)-binding activity and brain-derived neurotrophic factor (BDNF) levels related to the therapeutic effects of antidepressants were determined. Repeated administration of imipramine (1.25-10 mg/kg, i.p.) or rolipram (1.25 mg/kg, i.p.) reduced the number of escape failures in learned helplessness rats. Imipramine could not completely ameliorate the escape behavior to a level similar to that of non-stressed rats even at 10 mg/kg. However, repeated coadministration of rolipram with imipramine (1.25 and 2.5 mg/kg, respectively) almost completely eliminated the escape failures in learned helplessness rats. The reduction of CRE-bi...Continue Reading

References

Feb 15, 1988·Biological Psychiatry·J L HaraczE G Zimmermann
May 1, 1988·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·W Krause, G Kühne
Jan 1, 1984·Psychopharmacology·P Willner
Jan 1, 1996·Annual Review of Pharmacology and Toxicology·R K SunaharaA G Gilman
Jan 1, 1997·Pharmacology, Biochemistry, and Behavior·J A SiuciakR M Lindsay
Apr 24, 1997·Nature·W C DrevetsM E Raichle
Sep 2, 1998·Progress in Neuro-psychopharmacology & Biological Psychiatry·D FrechillaJ Del Río
Oct 2, 1998·Biological Psychiatry·R S Duman
Oct 21, 1999·European Journal of Pharmacology·Y NakagawaT Takashima
Jan 5, 2000·The American Journal of Psychiatry·J D BremnerD S Charney
Jan 14, 2000·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·K FujimakiR S Duman
May 22, 2002·European Journal of Pharmacology·Rosa M TorderaBerta Lasheras
Jul 18, 2002·Behavioural Pharmacology·P Willner, P J Mitchell
Aug 16, 2002·Bipolar Disorders·Carrol D'Sa, Ronald S Duman
Jul 3, 2003·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Jessica E Malberg, Ronald S Duman
Sep 5, 2003·The Journal of Pharmacology and Experimental Therapeutics·Yu ZhaoJames M O'Donnell
Dec 11, 2003·Journal of Neural Transmission·N DriguesM B H Youdim
Feb 27, 2004·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Alana C ContiJulie A Blendy

❮ Previous
Next ❯

Citations

Mar 5, 2009·Journal of Medicinal Chemistry·John R CashmanJames M O'Donnell
Jul 1, 2005·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Barbara MontiAntonio Contestabile
Feb 23, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Tomi RantamäkiEero Castrén
Jun 20, 2008·Proceedings of the National Academy of Sciences of the United States of America·Sungho MaengHusseini K Manji
Dec 19, 2012·Respiratory Research·Paul StollMarek Lommatzsch
Nov 20, 2012·Indian Journal of Psychological Medicine·Dipesh S PatelParloop A Bhatt
May 16, 2008·Expert Opinion on Therapeutic Targets·Tomi Rantamäki, Eero Castrén
Jul 30, 2009·Expert Opinion on Emerging Drugs·Sidney H Kennedy, Sakina J Rizvi
Oct 16, 2007·Drug Discovery Today·Tobias B Halene, Steven J Siegel
Dec 23, 2006·Neurobiology of Disease·Zena DeMarchFrancesca Romana Fusco
Apr 22, 2008·Neurobiology of Disease·Zena DeMarchFrancesca Romana Fusco
Apr 8, 2014·Journal of Neuroscience Research·Vladimir S NaumenkoNina K Popova
Jul 28, 2015·Journal of Neurochemistry·Carmen Rodríguez-SeoaneJesús R Requena
Aug 29, 2006·Biological Psychiatry·Ari A GershonLeon Grunhaus
Mar 8, 2006·Pharmacology, Biochemistry, and Behavior·Li SongKinzo Matsumoto
Feb 7, 2006·Biological Psychiatry·Julie A Blendy
Oct 26, 2005·Trends in Pharmacological Sciences·Jessica E Malberg, Julie A Blendy
May 3, 2015·Behavioural Brain Research·Tatiana V IlchibaevaVladimir S Naumenko
Sep 21, 2011·Pharmacology, Biochemistry, and Behavior·Sheketha R HauserYousef Tizabi
Oct 12, 2013·European Journal of Pharmacology·Ming-Zi ZhangJiang-Ping Xu
Nov 21, 2012·The International Journal of Neuropsychopharmacology·Shinn-Won LimDoh Kwan Kim
Oct 22, 2008·Annals of Medicine·Karin EspositoMa-Li Wong
Jun 13, 2014·Journal of Psychopharmacology·James O FajemiroyeElson A Costa

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.